151 related articles for article (PubMed ID: 10198784)
1. Bile acid abnormalities in cholestatic liver diseases.
Salen G; Batta AK
Gastroenterol Clin North Am; 1999 Mar; 28(1):173-93. PubMed ID: 10198784
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid therapy in pregnant women with cholestasis.
Diaferia A; Nicastri PL; Tartagni M; Loizzi P; Iacovizzi C; Di Leo A
Int J Gynaecol Obstet; 1996 Feb; 52(2):133-40. PubMed ID: 8855091
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A
Curr Clin Pharmacol; 2007 May; 2(2):155-77. PubMed ID: 18690863
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Beuers U
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis.
Scher H; Bishop WP; McCray PB
Ann Pharmacother; 1997 Sep; 31(9):1003-5. PubMed ID: 9296240
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
10. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
Brites D
Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
[TBL] [Abstract][Full Text] [Related]
11. Influence of cholestasis on absorption of ursodeoxycholic acid.
Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
[TBL] [Abstract][Full Text] [Related]
12. Use of ursodeoxycholic acid in patients with liver disease.
Angulo P
Curr Gastroenterol Rep; 2002 Feb; 4(1):37-44. PubMed ID: 11825540
[TBL] [Abstract][Full Text] [Related]
13. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
[TBL] [Abstract][Full Text] [Related]
14. Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction.
Bessone F; Roma MG
Ann Hepatol; 2016; 15(3):442-7. PubMed ID: 27049500
[TBL] [Abstract][Full Text] [Related]
15. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study.
Eriksson LS; Olsson R; Glauman H; Prytz H; Befrits R; Rydén BO; Einarsson K; Lindgren S; Wallerstedt S; Wedén M
Scand J Gastroenterol; 1997 Feb; 32(2):179-86. PubMed ID: 9051880
[TBL] [Abstract][Full Text] [Related]
17. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
19. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
20. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.
Hofmann AF
Gut; 2003 Sep; 52(9):1239-41. PubMed ID: 12912852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
